Related Experiment Video
Updated: Jun 12, 2026
15:29
Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
Published on: August 5, 2016
Structural Characterization of the Type IV Secretion System in Brucella melitensis for Virtual Screening-Based
Jahnvi Kapoor1, Amisha Panda1, Raman Rajagopal2
1Protein Biology Lab, Department of Zoology, University of Delhi, Delhi110007, India.
Journal of Chemical Information and Modeling
|June 10, 2026
Summary
Brucellosis treatment can be advanced by targeting the Type IV Secretion System (T4SS) in Brucella melitensis. This study modeled the T4SS and identified three drug candidates for potential repurposing against this zoonotic disease.
Area of Science:
- Microbiology
- Structural Biology
- Computational Biology
Background:
- Brucellosis is a significant zoonotic disease caused by Brucella melitensis.
- Brucella melitensis lacks conventional virulence factors, relying on the Type IV Secretion System (T4SS) for pathogenesis.
Purpose of the Study:
- To computationally identify, model, and assemble the T4SS components of Brucella melitensis.
- To explore the T4SS as a drug target for Brucellosis therapy.
Main Methods:
- Integrated computational pipeline for T4SS identification and modeling.
- Template-based modeling using E. coli T4SS crystallographic data.
- Virtual screening and molecular dynamics simulations for drug discovery.
Main Results:
- Modeled Brucella melitensis T4SS exhibits conserved architecture with E. coli homologues.
- Identified three potential drug candidates (Ezetimibe, Chlordiazepoxide, Alloin) targeting VirB11 ATPase.
- Confirmed favorable protein-ligand interactions and stability through simulations.
Conclusions:
- The study provides structural insights into the Brucella melitensis T4SS.
- Identified drug candidates offer a promising avenue for antivirulence therapy against Brucellosis.
- Drug repurposing presents an effective strategy for Brucellosis treatment.
